Prostate Cancer Clinical Trial

Application of Megavoltage Imaging to Reduce Artifact After Seed Implants

Summary

This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male 50-80 years of age Eligible for interstitial brachytherapy implants

Exclusion Criteria:

-

Study is for people with:

Prostate Cancer

Estimated Enrollment:

10

Study ID:

NCT01810627

Recruitment Status:

Completed

Sponsor:

William St Clair

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Markey Cancer Center
Lexington Kentucky, 40536, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

10

Study ID:

NCT01810627

Recruitment Status:

Completed

Sponsor:


William St Clair

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider